# Pharma brands — share of voice

Data as of 2026-10-01 (last 12 months).

| Brand | Mentions | Share |
|---|---|---|
| Eli lilly | 130 | 16% |
| Astrazeneca | 78 | 10% |
| Pfizer | 64 | 8% |
| Johnson & johnson | 59 | 7% |
| Novo nordisk | 46 | 6% |
| Merck | 44 | 5% |
| Sandoz | 41 | 5% |
| Moderna | 38 | 5% |
| Bayer | 36 | 4% |
| Roche | 36 | 4% |
| Novartis | 36 | 4% |
| Egis | 35 | 4% |
| Lilly | 23 | 3% |
| J&j | 21 | 3% |
| Well Pharmacy | 20 | 2% |
| Abbott | 19 | 2% |
| Polpharma | 15 | 2% |
| Sanofi | 13 | 2% |
| Biontech | 10 | 1% |
| Krka | 8 | 1% |
| ProCare | 7 | 1% |
| Dr. Max | 7 | 1% |
| Gsk | 6 | 1% |
| Boehringer | 5 | 1% |
| Abbvie | 3 | 0% |
| Fresenius | 2 | 0% |
| Medtronic | 2 | 0% |
| Zentiva | 2 | 0% |
| Adamed | 2 | 0% |
| Gedeon Richter | 2 | 0% |
| Pliva | 2 | 0% |
| Farmacias del Ahorro | 2 | 0% |
| Siemens healthineers | 1 | 0% |

Data: VoilàIQ, 2026-10-01. Canonical: https://voilaiq.com/brand-catalog/sector/pharma